Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors
- 27 June 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 66 (12) , 1899-1906
- https://doi.org/10.1212/01.wnl.0000219767.49705.9c
Abstract
Objective: To assess the value of spectroscopic and perfusion MRI for glioma grading and for distinguishing glioblastomas from metastases and from CNS lymphomas. Methods: The authors examined 79 consecutive patients with first detection of a brain neoplasm on nonenhanced CT scans and no therapy prior to evaluation. Spectroscopic MRI; arterial spin-labeling MRI for measuring cerebral blood flow (CBF); first-pass dynamic, susceptibility-weighted, contrast-enhanced MRI for measuring cerebral blood volume; and T1-weighted dynamic contrast-enhanced MRI were performed. Receiver operating characteristic analysis was performed, and optimum thresholds for tumor classification and glioma grading were determined. Results: Perfusion MRI had a higher diagnostic performance than spectroscopic MRI. Because of a significantly higher tumor blood flow in glioblastomas compared with CNS lymphomas, a threshold value of 1.2 for CBF provided sensitivity of 97%, specificity of 80%, positive predictive value (PPV) of 94%, and negative predictive value (NPV) of 89%. Because CBF was significantly higher in peritumoral nonenhancing T2-hyperintense regions of glioblastomas compared with metastases, a threshold value of 0.5 for CBF provided sensitivity, specificity, PPV, and NPV of 100%, 71%, 94%, and 100%. Glioblastomas had the highest tumor blood flow values among all other glioma grades. For discrimination of glioblastomas from grade 3 gliomas, sensitivity was 97%, specificity was 50%, PPV was 84%, and NPV was 86% (CBF threshold value of 1.4), and for discrimination of glioblastomas from grade 2 gliomas, sensitivity was 94%, specificity was 78%, PPV was 94%, and NPV was 78% (CBF threshold value of 1.6). Conclusion: Perfusion MRI is predictive in distinguishing glioblastomas from metastases, CNS lymphomas and other gliomas vs MRI and magnetic resonance spectroscopy.Keywords
This publication has 29 references indexed in Scilit:
- Characterization of brain tumors by MRS, DWI and Ki-67 labeling indexJournal of Neuro-Oncology, 2005
- Correlation of Molecular Genetics with Molecular and Morphological Imaging in Gliomas with an Oligodendroglial ComponentClinical Cancer Research, 2004
- Assessment of Irradiated Brain Metastases by Means of Arterial Spin-Labeling and Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MRIInvestigative Radiology, 2004
- Comparison of Arterial Spin-Labeling Techniques and Dynamic Susceptibility-Weighted Contrast-Enhanced MRI in Perfusion Imaging of Normal Brain TissueInvestigative Radiology, 2003
- Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imagingJournal of Magnetic Resonance Imaging, 2003
- Using Relative Cerebral Blood Flow and Volume to Evaluate the Histopathologic Grade of Cerebral Gliomas: Preliminary ResultsAmerican Journal of Roentgenology, 2002
- Simple and Effective Confidence Intervals for Proportions and Differences of Proportions Result from Adding Two Successes and Two FailuresThe American Statistician, 2000
- Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.American Journal of Roentgenology, 1998
- Intracranial meningeomas: Time- and dose-dependent effects of irradiation on tumor microcirculation monitored by dynamic MR imagingMagnetic Resonance Imaging, 1997
- The area above the ordinal dominance graph and the area below the receiver operating characteristic graphJournal of Mathematical Psychology, 1975